Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone

By Ward Alexandra   Bozkaya Duygu   Fleischmann Jochen   Dubois Dominique   Sabatowski Rainer   Caro J. Jaime  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2333-2345

Informa Healthcare

Access to resources Recommend Favorite

Controlled-release systems in neuropathic pain

By Shankarappa Sahadev A   Kohane Daniel S  

Pain Management, Vol. 3, Iss. 2, 2013-03 ,pp. : 91-93

Future Medicine

Access to resources Recommend Favorite

Health-Related Quality-of-Life Outcomes in Patients Treated with Push-Pull OROS Hydromorphone versus Extended-Release Oxycodone for Chronic Hip or Knee Osteoarthritis Pain: A Randomized, Open-Label, Parallel-Group, Multicenter Study

By Gajria Kavita  

The Patient: Patient-Centered Outcomes Research, Vol. 1, Iss. 3, 2008-01 ,pp. : 223-238

Adis International

Access to resources Recommend Favorite

Clinical spectrum of the osmotic-controlled release oral delivery system (OROS), an advanced oral delivery form

By Conley Robert   Gupta Suneel K.   Sathyan Gayatri  

Current Medical Research and Opinion, Vol. 22, Iss. 10, 2006-10 ,pp. : 1879-1892

Informa Healthcare

Access to resources Recommend Favorite

The use of high doses of OROS hydromorphone in an acute palliative care unit

By Mercadante Sebastiano  

Current Medical Research and Opinion, Vol. 27, Iss. 12, 2011-12 ,pp. : 2373-2376

Informa Healthcare

Access to resources Recommend Favorite